Ocular cancer
MONDO:0002236A benign or malignant neoplasm affecting the structures of the eye.
Also known as: eye neoplasm, neoplasm of eye, ocular tumor, ocular tumour, cancer of eye, cancer of eyeball of camera-type eye, cancer of the eye, eye cancer
2990 clinical trials for this condition and its sub-types, 10 tagged with Ocular cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ocular cancer
-
Ocular melanoma 15 trials · 107 incl. sub-types
6 sub-types
- Uveal melanoma 98 trials · 102 incl. sub-types Sub-types →
- Malignant conjunctival melanoma 4 trials
- Ocular melanoma with extraocular extension 1 trial
- Eyelid melanoma 0 trials
- Malignant cornea melanoma 0 trials
- Retinal melanoma 0 trials
-
Uveal cancer 2 trials · 102 incl. sub-types
3 sub-types
- Uveal melanoma 98 trials · 102 incl. sub-types Sub-types →
- Choroid cancer 0 trials · 10 incl. sub-types Sub-types →
- Iris cancer 0 trials · 4 incl. sub-types Sub-types →
-
Retinal cancer 2 trials · 35 incl. sub-types
3 sub-types
- Retinal cell cancer 0 trials · 34 incl. sub-types Sub-types →
- Retina lymphoma 1 trial
- Retinal melanoma 0 trials
-
Eye lymphoma 0 trials · 16 incl. sub-types
5 sub-types
- Intraocular lymphoma 13 trials
- Primary vitreoretinal large b-cell lymphoma 3 trials
- Primary lymphoma of the conjunctiva 1 trial
- Retina lymphoma 1 trial
- Primary oculocerebral lymphoma 0 trials
-
Conjunctival cancer 0 trials · 5 incl. sub-types
3 sub-types
- Malignant conjunctival melanoma 4 trials
- Primary lymphoma of the conjunctiva 1 trial
- Conjunctival squamous cell carcinoma 0 trials
-
Eye carcinoma 0 trials · 5 incl. sub-types
9 sub-types
- PAX6-related ocular dysgenesis 0 trials · 2 incl. sub-types Sub-types →
- Eyelid carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Ocular sebaceous carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Aniridia 2 0 trials
- Aniridia 3 0 trials
- Conjunctival squamous cell carcinoma 0 trials
- Cornea squamous cell carcinoma 0 trials
- Eye carcinoma in situ 0 trials
- Lacrimal gland carcinoma 0 trials Sub-types →
-
Eyelid cancer 3 trials · 4 incl. sub-types
2 sub-types
- Eyelid carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Eyelid melanoma 0 trials
-
Cornea cancer 0 trials
2 sub-types
- Cornea squamous cell carcinoma 0 trials
- Malignant cornea melanoma 0 trials
-
Lacrimal system cancer 0 trials
2 sub-types
- Lacrimal duct cancer 0 trials
- Lacrimal gland cancer 0 trials Sub-types →
Most studied deeper sub-types
-
New eye injection could spare sight in melanoma patients
Disease control OngoingThis Phase 3 trial tests a new drug called belzupacap sarotalocan (AU-011) for people with small choroidal melanoma or suspicious spots in the eye. The drug is injected into the eye and activated by a laser to target cancer cells. The study compares it to a sham (fake) procedure …
Phase 3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat eye cancer?
Disease control OngoingThis trial tests an experimental drug called DYP688 in people with metastatic uveal melanoma, a rare eye cancer that has spread, and other melanomas with specific genetic mutations. The study aims to find a safe dose and see whether the drug can shrink tumors. Participants receiv…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug combo shows promise against rare eye cancer
Disease control OngoingThis study tests whether combining two drugs, binimetinib and belinostat, can shrink or stop the growth of metastatic uveal melanoma, a rare eye cancer that has spread. About 7 adults with this condition are taking part. The main goal is to see how many patients respond to the tr…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New ultrasound technique could spot eye tumors without a biopsy
Diagnosis OngoingThis study tests a special ultrasound technique called Superb Microvascular Imaging (SMI) to see blood flow inside eye tumors. The goal is to help doctors tell benign from malignant tumors more accurately, especially when standard tests are unclear. Twenty-two adults with untreat…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC